Predictors of skeletal-related events among cancer patients with bone metastases treated with zoledronic acid: a secondary analysis of a randomized study.

Published in: Expert opinion on drug safety (2018)

this clinical trial was registered at clinicaltrials.gov with the number: nct0033.

Keyphrases